Free Trial

Aptevo Therapeutics (APVO) Earnings Date, Estimates & Call Transcripts

Aptevo Therapeutics logo
$4.80 +0.04 (+0.84%)
Closing price 04:00 PM Eastern
Extended Trading
$4.79 -0.01 (-0.21%)
As of 07:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Aptevo Therapeutics Earnings Summary

Aptevo Therapeutics posted Q1 2026 earnings on May 13, 2026, reporting an EPS of -$6.41, which missed analysts' consensus estimates of -$5.60 by $0.81. With a trailing EPS of -$1,770.33, Aptevo Therapeutics' earnings are expected to grow next year, from ($20.99) to ($18.65) per share.

Q1 2026 Earnings Resources

Latest Q1 2026
Earnings Date
May. 13Estimated
Consensus EPS
(May. 13)
-$5.60
Actual EPS
(May. 13)
-$6.41 Missed By -$0.81
Get Aptevo Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aptevo Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

APVO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Aptevo Therapeutics Analyst EPS Estimates

Current Year EPS Consensus Estimate
($20.99) EPS
Next Year EPS Consensus Estimate
($18.65) EPS

Aptevo Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/13/2026Q1 2026-$5.60-$6.41 -$0.81-$6.41--
3/26/2026Q4 2025-$8.10$118.23+$126.33$118.23--
11/6/2025Q3 2025-$37.62-$40.14 -$2.52-$2.23--
8/11/2025Q2 2025-$1,497.60-$151.20+$1,346.40-$8.40--
5/15/2025Q1 2025-$1,515.60-$1,580.40 -$64.80-$4.39--
8/8/2024--$951,181.20-$823,042.80+$128,138.40-$1.67--

Data powered by Fiscal.ai.

Aptevo Therapeutics Earnings - Frequently Asked Questions

Aptevo Therapeutics (NASDAQ:APVO) last announced its quarterly earning data on Wednesday, May 13, 2026. Learn more on APVO's earnings history.

In the previous quarter, Aptevo Therapeutics (NASDAQ:APVO) missed the analysts' consensus estimate of ($5.60) by $0.81 with a reported earnings per share (EPS) of ($6.41). Learn more on analysts' earnings estimate vs. APVO's actual earnings.

Aptevo Therapeutics (NASDAQ:APVO) has a recorded net income of -$25.97 million. APVO has generated -$1,770.33 earnings per share over the last four quarters.

Aptevo Therapeutics' earnings are expected to grow from ($20.99) per share to ($18.65) per share in the next year.


This page (NASDAQ:APVO) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners